Ask AI
ASCENT 04 Safety Analysis
ASCENT-04: Safety Analysis of Phase III Trial of Pembrolizumab With Sacituzumab Govitecan or Chemotherapy in Previously Untreated PD-L1+ Metastatic TNBC

Released: December 16, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 16, 2025